Solid Biosciences (SLDB) Asset Utilization Ratio (2021 - 2023)

Solid Biosciences has reported Asset Utilization Ratio for 3 years, with the latest figure at 0.03 in Q1 2023.

• Quarterly Asset Utilization Ratio fell 54.62% year-over-year to 0.03 in Q1 2023, while the trailing twelve-month figure through Mar 2023 was 0.03 (down 54.62% YoY) and the FY2022 annual result came in at 0.03, down 51.32% from the prior year.
• Asset Utilization Ratio declined to 0.03 in Q1 2023 per SLDB's latest filing, from 0.04 in the prior quarter.
• Over five years, Asset Utilization Ratio peaked at 0.07 in Q2 2022 and troughed at 0.01 in Q1 2021.
• A 3-year average of 0.04 and a median of 0.04 in 2021 frame the typical range for Asset Utilization Ratio.
• The sharpest annual moves came in 2022 and 2023: Asset Utilization Ratio soared 279.86% in 2022, then plunged 54.62% in 2023.
• Over 3 years, Asset Utilization Ratio stood at 0.06 in 2021, then tumbled by 35.68% to 0.04 in 2022, then slumped by 30.8% to 0.03 in 2023.
• According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.03, 0.04, and 0.06 for Q1 2023, Q4 2022, and Q3 2022 respectively.